Harvard Bioscience

Yahoo Finance • last year

Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023

HOLLISTON, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced it will be presenting at the Benchmark Company 12th Annual Discovery One-on-One Investor Conference to be held Thursday December... Full story

Yahoo Finance • last year

Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023

HOLLISTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present to investors at the Southwest IDEAS Investor Conference on Thurs... Full story

Yahoo Finance • last year

Harvard Bioscience Announces Third Quarter 2023 Financial Results

Q3Revenuesof$25.4 millionQ3GrossMarginof58.1%Q3GAAPoperatinglossof$0.9million,adjustedoperatingincome$1.8 millionContinuedstrongoperatingcashflowdrovedebtreduction of$8.3million through Q3 HOLLISTON, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE... Full story

Yahoo Finance • last year

Harvard Bioscience to Showcase Latest Innovations in Preclinical and Organoid Research at Society for Neuroscience Conference on November 12-15, 2023

HOLLISTON, Mass., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that it will be showcasing its latest product innovations at the Society for Neuroscience (SfN) conference from November 12-15, 2... Full story

Yahoo Finance • last year

Harvard Bioscience and Etisense Announce Agreement for Supply and Distribution of DECRO Miniature Telemetry Jacket Platform for Pre-Clinical Research

Includes dedicated version for integration with Ponemah data management software from Data Sciences International (DSI) Expands reach of unique, non-invasive wearable monitoring for pre-clinical research across North American and European... Full story

Yahoo Finance • 2 years ago

Harvard Bioscience Set to Join Russell 2000® and 3000® Indexes

HOLLISTON, Mass., June 22, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced that it is set to join the Russell 2000® and Russell 3000 Indexes, according to preliminary membership informatio... Full story

Yahoo Finance • 2 years ago

Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer

HOLLISTON, Mass., June 20, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the appointment of Jennifer Cote as the Company’s Chief Financial Officer and Treasurer, effective June 19, 2023.... Full story

Yahoo Finance • 2 years ago

Harvard Bioscience, Inc. (NASDAQ:HBIO) is largely controlled by institutional shareholders who own 61% of the company

Key Insights Significantly high institutional ownership implies Harvard Bioscience's stock price is sensitive to their trading actions The top 11 shareholders own 51% of the company Insiders have bought recently If you want to know who r... Full story

Yahoo Finance • 2 years ago

Harvard Bioscience to Present at Sidoti Micro Cap Virtual Conference May 10th, 2023

HOLLISTON, Mass., May 02, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present and host one-on-one meetings with investors at the Sidoti Micro C... Full story

Yahoo Finance • 2 years ago

Harvard Bioscience Announces First Quarter 2023 Financial Results

Q1 Revenues of $30 million up 4% over prior year periodQ1 GAAP Operating Income of $1.7 million up from a loss of $6.7 million prior yearQ1 Adjusted Operating Income of $4.4 million up from $2.4 million prior year HOLLISTON, Mass., April... Full story

Yahoo Finance • 2 years ago

Harvard Bioscience Announces Initial Order for Integrated Animal Behavior Monitoring System

HOLLISTON, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the initial order for the Company’s new high-capacity behavioral monitoring system for pre-clinical applications... Full story

Yahoo Finance • 2 years ago

Harvard Bioscience Schedules First Quarter 2023 Earnings Conference Call for April 25, 2023 at 9:00 AM ET

Harvard Bioscience, Inc. HOLLISTON, Mass., April 17, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2023 before the market opens on April 25, 2023, and... Full story

Yahoo Finance • 2 years ago

Harvard Bioscience to Present at Sidoti Investor Conference March 22-23, 2023

HOLLISTON, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present and host one-on-one meetings with investors at the Sidoti Virtu... Full story

Yahoo Finance • 2 years ago

Harvard Bioscience to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 21, 2023

Yahoo Finance • 2 years ago

Harvard Bioscience Announces Fourth Quarter 2022 Financial Results

HOLLISTON, Mass., March 09, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the fourth quarter and year ended December 31, 2022. Our fourth quarter revenues were $28... Full story

Yahoo Finance • 2 years ago

Harvard Bioscience Schedules Fourth Quarter 2022 Earnings Conference Call for March 9, 2023 at 8:00 AM ET

HOLLISTON, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2022 before the market opens on March 9, 2023, and will hold a conferen... Full story

Yahoo Finance • 2 years ago

Harvard Bioscience Announces CFO Transition

HOLLISTON, Mass., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the resignation of Michael Rossi, the Company’s chief financial officer and treasurer, effective December 31, 202... Full story

Yahoo Finance • 2 years ago

President James Green Just Bought 2.3% More Shares In Harvard Bioscience, Inc. (NASDAQ:HBIO)

Even if it's not a huge purchase, we think it was good to see that James Green, the President of Harvard Bioscience, Inc. (NASDAQ:HBIO) recently shelled out US$75k to buy stock, at US$2.51 per share. Although the purchase is not a big one,... Full story

Yahoo Finance • 2 years ago

Harvard Bioscience Schedules Third Quarter 2022 Earnings Conference Call for November 8, 2022 at 4:30 PM ET

HOLLISTON, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for third quarter ended September 30, 2022 after the market closes on November 8, 2022, and will hold a confe... Full story

Yahoo Finance • 2 years ago

Harvard Bioscience Announces Second Quarter 2022 Financial Results

HOLLISTON, Mass., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the second quarter ended June 30, 2022. Jim Green, Chairman and CEO, said, "Our second qua... Full story